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Jak2 Is Essential for Signaling
through a Variety of Cytokine Receptors
in IFNa/b signaling in fibroblasts. Subsequently, it was
shown that the ability of erythropoietin (Epo) receptor
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the common gc receptor chain that was first identified
as an essential chain in the functional receptor for IL-2A variety of cytokines activate receptor-associated
(Leonard et al., 1995). The gc chain is also a criticalmembers of the Janus family of protein tyrosine ki-
component of the receptors for a variety of cytokinesnases (Jaks). To assess the role of Jak2, we have
that affect lymphoid functions, including IL-7, a cytokinederived Jak2-deficient mice. The mutation causes
that is essential for the expansion of early lymphoidan embryonic lethality due to the absence of defini-
progenitors (von Freeden-Jeffry et al., 1995). Mutanttive erythropoiesis. Fetal liver myeloid progenitors,
mice lacking Jak3 were shown to be viable but had aalthough present based on the expression of lineage
phenotype of severe combined immunodeficiency (SCIDs)specific markers, fail to respond to erythropoietin,
and functional deficiency of mature T and B cells consis-thrombopoietin, interleukin-3 (IL-3), or granulocyte/
tent with a critical, nonredundant role for Jak3 in themacrophage colony-stimulating factor. In contrast,
function of all the receptors utilizing the gc chain. Simi-the response to granulocyte specific colony-stimulat-
larly the absence of Jak3 in humans has been showning factor is unaffected. Jak2-deficient fibroblasts
to be associated with SCIDs (Macchiet al., 1995; Russellfailed to respond to interferon g (IFNg), although the
et al., 1995). These results have demonstrated that Jak3responses to IFNa/b and IL-6 were unaffected. Lastly,
plays an essential, nonredundant role in the functioningreconstitution experiments demonstrate that Jak2 is
of one group of cytokine receptorsof thecytokine recep-
not required for the generation of lymphoid progeni-
tor superfamily that is characterized by the use of the
tors, their amplification, or functional differentiation.
gc chain.Therefore, Jak2 plays a critical, nonredundant role in In the studies presented here, we have focused on
the function of a specific group of cytokines receptors. the role of Jak2 in cytokine signaling. Jak2 has been
shown to be the predominant Jak activated in the re-
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sponse to a wide variety of cytokines, including Epo
(Witthuhn et al., 1993), IL-3, and granulocyte/macro-
A variety of cytokines function through their ligation of phage colony-stimulating factor (GM-CSF) (Silvennoinen
members of the cytokine receptor superfamily. This fam- et al., 1993), IL-5, thrombopoietin (Tpo) (Drachman et
ily of receptors associates with and mediates ligand- al., 1995; Miyakawa et al., 1995; Tortolani et al., 1995),
dependent activation of members of the Janus family growth hormone (Artgetsinger et al., 1993), and prolactin
of protein tyrosine kinases (Jaks). The Jaks were first (Campbell et al., 1994; reviewed in Ihle, 1995). In addi-
identified by screens to detect novel protein tyrosine tion, it is activated, along with other Jaks, in the re-
kinases (Firmbach-Kraft et al., 1990; Wilks, 1991). The sponses to G-CSF (Shimoda et al., 1994), cytokines re-
potential function of this family of protein tyrosine ki- lated to IL-6 (Stahl et al., 1994) and IFNg (Guschin et al.,
nases was first indicated in studies of cell lines that 1995). However, in each of these cases, other cyto-
were defective in interferon (IFN) signaling (Velazquez plasmic protein tyrosine kinases are activated, and
et al., 1992). Isolation of genomic clones, capable of therefore it is unclear which have unique or redundant
reconstituting the response of one mutant to IFNa/b, roles in receptor signaling. To assess further the specific
resulted in the demonstration that Tyk2 was required role of Jak2 in these responses and to determine
whether Jak2 might be essential for other unknown re-
ceptor systems, we have developed mutant mice that9 To whom correspondence should be addressed.
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pregnancies demonstrated that homozygous embryos
could be identified by PCR analysis at 10±12 days (Fig-
ure 1B) but that such embryos were not present at later
times. Analysis of tissues from 10- to 12-day-old em-
bryos demonstrated that homozygously deficient em-
bryos lacked detectable Jak2 by immunoprecipitation
and Western blotting (data not shown).
The potential basis for the lethality was evident from
the appearance of the homozygous embryos (Figure 2,
top). At approximately 10 days of development, defini-
tive erythropoiesis initiates in the fetal liver and is evi-
dent from the bright red appearance of the organ as
illustrated in Figure 2 (top left) for wild-type animals. In
contrast, homozygous Jak2-deficient embryos lacked de-
tectable definitive erythropoiesis. By histological anal-
ysis of 11.5 day fetal livers, wild-type embryos contained
numerous hematopoietic elements (Figure 2, bottom
left). In contrast, fetal livers from mutant mice consisted
primarily of hepatic cells and, infrequently, nucleated,
primitive red cells or hematopoietic progenitors (Figure
2, bottom right). These aspects of the phenotype are
comparable to those observed in mice lacking Epo or
the receptor for Epo (Wu et al., 1995b) and demonstrate
that Jak2 plays an essential, nonredundant role in Epo
signal transduction.
To examine further thepotential effects of theabsenceFigure 1. Disruption of the Jak2 Locus by Homologous Recombi-
nation of Jak2 on erythropoiesis, as well as other cytokines
(A) To obtain mice in which the Jak2 locus was functionally inacti- responses, fetal liver cells from 10-day-old embryos
vated, a targeting construct was developed that would remove the were examined for their ability to respond in colony
second coding exon and flanking sequences as indicated. The con- formation to several cytokines (Table 1). Consistent with
struct contained 4.5 kb 59 flanking sequences and 2.5 kb 39 flanking the above results, erythroid colony-forming units (CFU-E)
sequences. The restriction maps of the Jak2 locus and the targeting
were not detected in fetal liver cells from mutant miceconstruct are indicated. The restriction enzymes include Sst (SacI),
but were readily detectable with cells from wild-typeH (HindIII), S1 (SalI), X(XbaI), R1 (EcoRI), Sp (SpeI), and RV (EcoRV).
The construct contained a neomycin gene and the Herpes virus embryos or heterozygous embryos (data not shown).
thymidine kinase (TK) gene for selection. The location of primers Fetal liver cells from mutant mice also failed to respond
sequences used in the characterization of the locus are shown. to IL-3, in the presence or absence of Epo, in the forma-
(B) PCR analysis of tissues from 10- to 12-day-old embryos. Tissues tion of mixed lineage colonies or erythroid lineage burst
from the embryos were examined by PCR for the presence of the
forming units (BFU-E). In addition, fetal liver cells faileddisrupted locus as described in Experimental Procedures.
to respond to Tpo in the formation of megakaryocytic
colonies. Lastly, thecells failed to respond to GM-CSF or
IL-5 (data not shown). The results therefore demonstrate
are deficient in Jak2 through gene disruption in embry-
that Jak2 has a critical, nonredundant role in the function
onic (ES) cells. The results demonstrate that Jak2 plays
of IL-3, GM-CSF, IL-5, and Tpo.
an essential, nonredundant role in the function of a num- G-CSF has been shown to cause the activation of
ber of these cytokines. Jak1, Jak2, and Tyk2 (Shimoda et al., 1997). Studies
with mutant cell lines have suggested that the presence
Results of Jak1 was critical for the responses toG-CSF, whereas
the presence of Jak2 was not required. As illustrated in
To disrupt the Jak2 gene, a genomic targeting vector Table 1, fetal liver cells from mutant mice responded to
was constructed that would delete the second coding G-CSF in the formation of granulocytic colonies at levels
exon of the Jak2 gene and would be anticipated to comparable to wild-type animals, indicating that in the
generate a protein null mutation (Figure 1A). The con- granulocytic lineage, Jak2 is either not required or is
struct was used to obtain nine clones of ES cells that redundant to the activation of other Jaks. The presence
contained an appropriately disrupted allele. Individual of G-CSF responsive cells also indicates that hemato-
clones of targeted ES cells were injected into C57Bl/6 poietic lineage precursor cells are present in Jak2-defi-
blastocysts and implanted into pseudopregnant fe- cient mice.
males. Chimeric mice were bred to obtain germ line The above cytokines utilize receptors of the cytokine
transmission. Four independently derived clones of ES receptor superfamily. In contrast, CSF-1 and SCF utilize
cells gave rise to mutant strains, all of which had identi- protein tyrosine kinase receptors. It was therefore im-
cal phenotypes. Heterozygous animals were phenotypi- portant to assess the effect of Jak2 deficiency on their
cally normal and were bred to obtain mice homozygous responses. As illustrated in Table 1, fetal liver cells from
for the disrupted allele. Typing of the progeny of such both wild-type and mutant mice were capable of forming
crosses resulted in the absence of viable homozygous macrophage colonies in response to CSF-1, although
the numbers were reduced relative to wild-type mice.mice indicating embryonic lethality. Analysis of timed
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Figure 2. Morphological Phenotype of Jak2-Deficient Embryos
Embryos were dissected from the embryo sacks and were photographed. Top left panel shows the morphology of a wild-type embryo, while
the morphology of the Jak2-deficient embryo is illustrated on the top right. The mutant embryo is characterized by the visually obvious
absence of red cells in the fetal liver and surrounding tissues. The histological appearance of the wild-type and mutant fetal livers are shown
on the bottom left and right, respectively. The wild-type fetal liver contains a mixture of fetal hepatocytes and myeloid cells, including
erythroblasts and red cells. The mutant fetal livers contain predominantly fetal hepatocytes with few myeloid lineage cells. A few nucleated,
primitive red cells are present.
The reduction may reflect a requirement for Jak2 in the and Gata-2 (Tsai et al., 1994). Interestingly, a few genes
were expressed at reduced levels and were at levelsamplification of progenitors as discussed below. Simi-
larly, the number of mixed colonies formed in response comparable to the levels of the Epo receptor, including
c-myb and Pu.1, both of which are required for earlyto SCF was reduced, but colonies were present. It
should be noted that in the response to SCF, no mature myeloid lineages (Mucenski et al., 1991; Scott et al.,
1994). We also determined the presence of globin genered cellswere observed in the colonies (data not shown),
demonstrating that SCF alone is not capable of support- transcripts that are differentially regulated during devel-
opment (Whitelaw et al., 1990). Transcripts for all theing full erythroid differentiation.
The absence of Epo, IL-3, and Tpo responsive cells globin genes were detectable, including the predomi-
nantly embryonic ey2, z, and bh1 genes as well as the acould be due toan essential role for Jak2 in their function
or could be due to the absence of responsive progeni- gene that is expressed embryonically and in defini-
tive erythropoiesis. Lastly, expression of the bmaj gene,tors. To address the later possibility, fetal liver cells
were examined for the expression of a variety of genes whose expression is initiated in fetal liver definitive
erythropoiesis, was also detected, although at levelsassociated with hematopoietic progenitors (Figure 3).
Consistent with the hypothesis that hematopoietic pro- lower than controls. This is consistent with the lack of
expansion of definitive erythrocytes.genitors were present was the ability to detect the ex-
pression of a number of genes characteristic of early Another approach to assessing the presence of ery-
throid lineage progenitors involved the use of retroviralhematopoiesis. In particular, transcripts for the Epo re-
ceptor were present, although at a reduced level, as vectors to attempt to rescue erythroid lineage cells. In
these experiments, fetal liver cells from 10- to 12-day-were transcripts for EKLF, which is essential for globin
expression during red cell development (Nuez et al., old embryos were obtained and infected in cultures with
a retroviral construct capable of expressing Jak2. The1995; Perkins et al., 1995). Other genes that are required
for definitive erythropoiesis and hematopoiesis were de- cells were subsequently plated in colony assays with
Epo to assess their ability togenerate erythroid colonies.tectable, including AML1 (Okuda et al., 1996), rhom-
botin-2 (Warren et al., 1994), Gata-1 (Pevny et al., 1991), As shown in Table 1, CFU-E could be rescued from
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Table 1. Colony Formation Ability of Hematopoietic Progenitors in Liver Cells from Jak2 Wild-Type and Mutant Mice in Response to
Various Cytokines
Genotype
Colony Type Jak21/1 Jak22/2
Cytokine
Epoa CFU-E 739 6 35 (n 5 6) 0 6 0 (n 5 6)
IL-3 1 Epo BFU-E 9 6 1 (n 5 6) 0 6 0 (n 5 6)
IL-3 1 Epo CFU-Mix 62 6 4 (n 5 6) 0 6 0 (n 5 6)
IL-3 CFU-Mix 213 6 12 (n 5 6) 0 6 0 (n 5 6)
TPO CFU-Meg 30 6 3 (n 5 6) 0 6 0 (n 5 6)
G-CSF CFU-G 62 6 6 (n 5 4) 60 6 6 (n 5 4)
CSF-1 CFU-M 420 6 45 (n 5 4) 143 6 9 (n 5 4)
SCF CFU-Mix 101 6 4 (n 5 4) 31 6 4 (n 5 4)
Retroviral Transductionb
Epo 1 IL-3 CFU-Mix 92/105 20/31
Epo CFU-E 776/841 95/112
a Mean 6 standard deviation of number of colonies/105 liver cells.
b Fetal liver cells were obtained from either wild-type or Jak2-deficient embryos at 10±11 days of gestation. The cells were cultured with a
Jak2-expressing retrovirus overnight and plated in colony assays as described in Experimental Procedures. The results indicate the colonies
per 105 cells plated, and the results from two animals are given.
Jak2-deficient fetal liver cells by infection with the Jak2 bers of B220-positive cells (panel 2). Reconstitution of
sublethally irradiated Jak3-deficient mutant mice withretrovirus, although the numbers of colonies present per
105 cells were reduced relative to the number seen with fetal liver cells from either wild-type embryos (panel
3) or Jak2 mutant embryos (panel 4) resulted in thefetal liver cells from wild-type embryos. This reduction
suggests that, although committed progenitors can be appearance of peripheral B cells. To assess the contri-
bution of the Jak2-deficient cells to peripheral lymphoidgenerated, they cannot be expanded or maintained in
the absence of Jak2. cells, PCR analysis was done to detect the mutant cells.
As shown in Figure 4B, the mutant cells from the Jak2-Fetal liver cells from normal 10- to12-day-old embryos
also contain progenitors for the lymphoid lineages. It deficient embryos were readily detectable in the periph-
eral lymphocytes of the reconstituted Jak3-deficientwas therefore important to determine whether such pro-
genitors could be generated in mice that lack Jak2. For mice.
The above results demonstrate that Jak2 is not re-these experiments, fetal liver cells from 10- to 12-day-
old wild-type and Jak2-deficient embryos were used to quired for the generation of lymphoid progenitors during
embryonic development and that it is not required forreconstitute sublethally irradiated Jak3-deficient mice.
As we have previously shown (Nosaka et al., 1995), Jak3 the expansion of B cell progenitors in mice. To assess
the potential contribution to other lymphoid functions,is essential for the amplification of early lymphoid pro-
genitors and for the function of a number of cytokine we examined lymphocytes from the reconstituted mice.
The ability to reconstitute the T cell lineage was evidentreceptors that utilize the gc receptor chain and regulate
a variety of lymphoid functions. Four weeks following from the number of thymocytes and peripheral T cells.
As illustrated in Figure 5B, few CD41 CD81, double posi-reconstitution of Jak3-deficient mice, the mice were ex-
amined for the presence of peripheral, B220-positive B tive cells were present in the thymus of a Jak3 deficient,
nonreconstituted mouse. In contrast, the frequencies ofcells (Figure 4A). As shown, normal mice have readily
detectable peripheral B cells (panel 1), while Jak3-defi- double positive cells in thymi from reconstituted mice
(Figures 5C and 5D) were similar to those seen in thecient mutant mice are dramatically reduced in the num-
Figure 3. Expression of Myeloid Lineage Marker Genes in Fetal Livers of Jak2-Deficient Mice
Polymerase chain reactions were used to assess the presence of a variety of genes that are involved in myeloid differentiation. RNA was
obtained from the fetal livers of 10- to 12-day-old embryos of either wild-type (WT) or Jak2-deficient (KO) embryos. The RNA was used to
make cDNA, using random primers and an oligo(dT) primer, and the cDNA was used in reactions to amplify segments of the indicated genes.
The primers for the various reactions have been previously described (Okuda et al., 1996).
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or LPS (data not shown). Together the results demon-
strate that Jak2 is not required for the embryonic devel-
opment of progenitors capable of reconstituting the
lymphoid lineages and is not required for the cytokine
functions examined.
In addition to a number of cytokines that affect my-
eloid lineages, Jak2 activation is observed in the re-
sponses to cytokines of the IL-6 family as well as IFNg
but not in the response to IFNa/b. Consistent with the
latter observations, previous studies with mutant cell
lines (Watling et al., 1993) had suggested a critical role
for Jak2 in IFNg but not IFNa/b responses. To assess
the role of Jak2 in these responses, fibroblasts were
derived from wild-type and Jak2-deficient embryos and
examined for their ability to respond to various cyto-
kines. As illustrated in Figure 6A, cells from both Jak2-
deficient and wild-type embryos responded to IL-6 as
assessed by tyrosine phosphorylation of Jak1 and Tyk2,
and gp130 and Stat3. Moreover, IL-6 was able to induce
the expression of a characteristic response gene (IRF-1)
as illustrated in Figure 6E. Similarly, fibroblasts from
both wild-type and mutant mice responded comparably
to IFNa/b as assessed by tyrosine phosphorylation of
Jak1, Tyk2, and Stat1 (Figure 6B), as well as by the ability
to induce IRF-1 gene expression (Figure 6E). However,
unlike fibroblasts from wild-type embryos, fibroblasts
from Jak2-deficient embryos were unable to respond to
IFNg as assessed by tyrosine phosphorylation of Jak1 or
Stat1 (Figure 6C) or by the induction of IRF-1 or SOCS-1,
another IFN response gene (Figure 6D).
As an additional assay for Jak2 function in IFNg signal-
ing, we assessed the ability of IFNg to protect against
the cytopathic effects of encephalomyocarditis virus
(EMCV). Cells were treated with various concentrations
of IFNg for 16 hr, removed from IFNg, and infected with a
dilution of EMCV that would produce a 100% cytopathic
effect in 24 hr of untreated cells. Wild-type cells were
Figure 4. Reconstitution of the Lymphoid Lineages of Jak3-Defi- protected from EMCV-induced cytopathy with increas-
cient Mice by Fetal Liver Cells from Jak2-Deficient Embryos ing doses of IFNg. However, fibroblasts from Jak2-defi-
(A) Jak3-deficient mice were sublethally irradiated and reconstituted cient embryos were not protected even at 1000 U/ml of
by injection of fetal liver cells from wild-type embryos or Jak2- IFNg (data not shown). Therefore, Jak2 is required for
deficient embryos. Four weeks after reconstitution, blood was ob-
the antiviral response mediated by IFNg.tained by retroorbital bleeding and analyzed by fluorescence acti-
vated cell sorting for the presence of B220-positive, peripheral B
cells. The samples shown include wild-type mice (1), Jak3-deficient
Discussionmice (2), and Jak3-deficient mice reconstituted with wild-type fetal
liver cells (3) or with fetal liver cells from Jak2-deficient embryos (4).
(B) To assess the contribution of cells from Jak2-deficient fetal liver The results demonstrate that Jak2 is required for the
cells, a PCR reaction was used to detect the presence of the altered function of a variety of cytokine receptors. A potential
allele. The samples examined include a control (C) and samples
role for Jak2 in cytokine signaling was initially suggestedfrom peripheral blood as in (A).
in studies of the receptors for growth hormone (Artget-
singer et al., 1993), Epo (Witthuhn et al., 1993), and IL-3
(Silvennoinen et al., 1993). However, in the case of thethymus from a wild-type mouse (Figure 5A). The func-
tionality of these T cells was examined by assessing Epo or IL-3 receptors, a number of kinases have been
implicated in signaling. For example, Tec (Machide ettheir ability to respond by proliferation to engagement
of the T cell receptor in the presence or absence of IL-2. al., 1995) (Mano et al., 1995), fes (Hanazono et al., 1993),
syk (Tsubokawa et al., 1997), and lyn (Torigoe et al.,As shown, T cells from Jak3-deficient mice that had
been reconstituted with fetal liver cells from Jak2-defi- 1992a; 1992b) have all been reported to be activated in
the response to IL-3 and/or Epo and have been specu-cient embryos proliferated following stimulation with in-
creasing concentrations of anti-CD3 (E)or IL-2 (F),whereas lated to play a critical role. Moreover, as discussed be-
low, it has been hypothesized that c-kit associates withcells from nonreconstituted mice failed to respond under
either conditions. In addition, B cells from Jak3-deficient the Epo receptor and was speculated to mediate Jak2
independent activation of Epo receptor signaling. Be-mice, reconstituted with fetal liver cells from Jak2-defi-
cient embryos, were capable of responding to anti-IgM cause of the possible redundant involvement of other
Cell
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Figure 5. Functional Reconstitution of the
Lymphoid Lineages by Jak2-Deficient Fetal
Liver Cells
Jak3-deficient mice were sublethally irradi-
ated and reconstituted with fetal liver cells
from Jak2-deficient embryos as in Figure 4.
The ability to reconstitute the thymocyte pop-
ulations was examined by analysis of the ex-
pression of the T lineage markers, CD4 and
CD8. Thymocytes from normal mice express
both CD4 and CD8 (A), while the thymuses
of Jak3-deficient mice are greatly reduced in
this subset of cells (B). Reconstitution of
Jak3-deficient mice with wild-type (C) or Jak2-
deficient fetal liver cells (D) resulted in a com-
parable reconstitution of the double positive
population. The functional capabilities of pe-
ripheral T cells was examined by assessing
their ability to proliferate to increasing con-
centrations of anti-CD3 (E) or to proliferate
to a limiting concentration of anti-CD3 in the
presence of increasing concentrations of IL-2
(F). The samples shown include cells from
wild-type mice (open triangles), Jak3-defi-
cient mice (open circles), Jak3 mice reconsti-
tuted with fetal liver cells from wild-type mice
(filled circles), or Jak2-deficient embryos
(filled rectangles).
cytoplasmic tyrosine kinases, it was possible that dele- cytokines are absent, the results would suggest that
none of these cytokines is essential, even in a potentiallytion of Jak2 would not have had a demonstrable pheno-
type like the deletion of the other cytoplasmic protein redundant manner, for the generation of early hemato-
poietic progenitors.tyrosine kinases implicated in signaling.
The phenotype of Jak2-deficient embryos is very simi- Previous studies (Wu et al., 1995a) suggested that
SCF, through its receptor, c-kit, could induce tyrosinelar to that of the Epo or Epo receptor mutant mice (Wu
et al., 1995b). However, the reduction inerythropoiesis in phosphorylation of the Epo receptor and that c-kit asso-
ciates with the Epo receptor as assessed by GST-fusionJak2-deficient mice appears somewhat more profound
than that reported for Epo- or Epo receptor±deficient proteins. Based on these results, it was hypothesized
that c-kit transduced a mitogenic or differentiation sig-mice. This could be due to the inactivation of Tpo func-
tion, since Tpo contributes to the expansion of early nal through the Epo receptor that was independent of
Jak2 activation. This model was evoked to explain theerythroid lineage cells and can rescue in vitro erythroid
colony formation from mouse embryos lacking the Epo reduction of erythroid lineage cells seen in c-kit mutant
mice. Our results are not consistent with this hypothesisreceptor (Kieran et al., 1996). Importantly, however, pro-
genitors for the erythroid lineage are present as indi- and demonstrate that Jak2 is essential for either Epo
receptor function in the induction of erythroid lineagecated by the expression of genes that are associated
with lineage committed cells as well as by the ability to expansion and differentiation, independent of whether
the receptor is activated by Epo or by SCF through c-kit.rescue erythroid lineage cells by infection with a retrovi-
rus expressing Jak2. The effects of c-kit mutations are therefore likely to be
upstream of the Epo signaling in the expansion of theThe responses to other cytokines including Tpo, GM-
CSF, IL-5, and IL-3 are also deficient in Jak2-deficient progenitors that become Epo responsive.
The development of the embryos until day 10±12mice. The later cytokines utilize a common signaling
chain, termed the b chain, which has been shown to is normal and suggests that Jak2 is not required, in
a nonredundant manner, for any early developmentalassociate with Jak2. Since the functions for all these
Jak2 Is Essential for Cytokine Signaling
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Figure 6. Fibroblasts from Jak2-Deficient Embryos Respond to IL-6 or IFNa but Not to IFNg
Fibroblasts were derived from either wild-type embryos (1/1) or Jak2-deficient embryos (2/2) as described in Experimental Procedures.
(A) To examine the response to IL-6 fibroblasts cultures were not stimulated (2) or were stimulated with a mixture of IL-6 and the soluble
IL-6 receptor a chain (IL6). Following 10 min of stimulation, the cells were collected and analyzed for the induction of tyrosine phosphorylation
of Jak1 or Tyk2, gp130 or Stat3 by immunoprecipitation with the indicated antisera and Western blotting with a monoclonal antibody against
phosphotyrosine. To control for protein loading, the anti-Stat3 immunoprecipitations were analyzed for Stat3 protein by Western blotting.
(B) The responses of the fibroblasts to IFNa/b were determined comparably except that the induction of tyrosine phosphorylation of Stat1
was examined.
(C) The response to IFNg was also comparably analyzed with the same exception.
(D) To assess further the ability to respond to IFNa, the induction IRF-1 or SOCS-1 was examined by Northern analysis 1 hr following stimulation
of fibroblasts.
(E) The ability of IFNa or IL-6 to induce IRF-1 expression was examined by Northern analysis as above. The levels of GAPDH RNA were used
to control for RNA loading.
events (Neubauer et al., 1998 [this issue of Cell]). We Jak2 does not detectably affect gp130-mediated signal-
ing by IL-6. Therefore, it is unlikely that the defects arehave, however, noticed a morphologically detectable
delay in heart development in the Jak2-deficient em- related to gp130 signaling. The possibility exists that
effects on the heart seen in Jak2-deficient mice may bebryos (data not shown). This was of potential interest
because previous studies described a defect in the de- related to the anoxia as a consequence of the profound
lack of definitive erythropoiesis and reduced primitivevelopment of the heart of gp130-deficient mice (Yoshida
et al., 1996) that may be due to the loss of function of erythropoiesis. Alternatively, red cells may produce cy-
tokines that contribute to myocardial development.cardiotropin, a cytokine that utilizes the gp130 cytokine
receptor chain (Hirota et al., 1995; Wollert and Chien, Fetal liver cells fromJak2-deficient embryos were able
to numerically reconstitute the lymphoid lineages in1997). However, the defect seen in gp130-deficient mice
occurs at 16.5 days of development and later. Moreover, Jak3-deficient mice. In addition, all the T and B cell
functions examined were functionally reconstituted.the results with fibroblasts suggest that the absence of
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These results demonstrate that Jak2, unlike Jak3, is not the stage when definitive erythropoiesis is required. The
results are consistent with the hypothesis that cyto-required for the embryonic development of lymphoid
lineage progenitors, for the IL-7 dependent expansion kines, cytokine receptors, the Jaks, and the Stats have
evolved to fulfill very specific functions acquired duringlymphoid lineage committed progenitors, or for the func-
tional differentiation of peripheral T and B cells. In con- evolution.
trast to these results, reconstitution of Jak3-deficient
Experimental Proceduresmice with AML1-deficient fetal liver cells does not result
in reconstitution (unpublished data), consistent with a
Construction of Jak2 Targeting Vectorcritical role for AML1 in early hematopoietic stem cell
The Jak2 gene was isolated from a 129/SvE mouse genomic library
function (Okuda et al., 1996). Although not addressed, in lEMBL3 using a 59 Jak2 cDNAprobe. Positiveclones wererestric-
one potentially interesting cytokine that affects T cell tion mapped, and the exon/intron structure of the 59-end of the gene
function is IL-12, which has been shown to activate Jak2 was determined by hybridization using 59 specific cDNA oligonucle-
otides or sequencing. For the Jak2 targeting vector, a 12.5 kb SalI(Bacon et al., 1995).
fragment was subcloned, followed by replacement of a 5 kb SpeI/G-CSF activates several of the Jak family members,
EcoRV fragment containing the second Jak2 coding exon with aincluding Jak1, Jak2, and Tyk2, although most studies
neomycin resistance cassette (van Deursen et al., 1991). A herpes
have observed that Jak2 is the most significantly acti- simplex thymidine kinase (HSV-tk) cassette mediating negative se-
vated (Nicholson et al., 1994, 1995; Rauprich et al., 1995; lection was inserted in the 39-end of the Jak2-neo construct.
Barge et al., 1996). Previous studies (Shimoda et al.,
1997) using mutant cell lines that are deficient in Jak2, Culturing and Electroporation of ES Cells
E14 (129/Ola mouse strain) ES cells were cultured in Dulbecco'sJak1, or Tyk2 suggested that the absence of Jak2 or
modified Eagle medium (D-MEM) containing 15% fetal calf serum,Tyk2 did not affect G-CSF receptor function but that in
1 mM sodium pyruvate, 2 mM L-glutamine, 0.1 mM nonessentialthe absence of Jak1, signaling was lost. The results
amino acids, 55 mM 2-mercaptoethanol, 10 mg/ml gentamicin, and
obtained with fetal liver cells from Jak2-deficient mice 1,000 U/ml LIF (all from GIBCO-BRL). Mitotically inactivated SNLH9
support the conclusion that Jak2 is not essential for a were used as feeder cells for the E14 ES cells. Twenty-five micro-
grams of NotI linearized Jak2 plasmid construct was electroporatedG-CSF response. Interestingly, studies with Jak1-defi-
into the ES cells using a gene pulser set at 0.23 kV, 500 mF (Bio-cient mice also suggest that Jak1 is not essential for a
Rad). Selection 24 hr after electroporation was in 350 mg/ml genet-G-CSF response (Rodig et al., 1998 [this issue of Cell]).
icin (G418 [GIBCO-BRL]) and 2 mM gancyclovir. ES clones wereIt is possible that the various Jaks activated by the G-CSF
picked and expanded 7±10 days after electroporation.
receptor fulfill redundant functions. Alternatively, it is
possible that other cytoplasmic kinases are involved. Generation of Jak2-Deficient Mice
Similar to the studies with G-CSF, the results with Conditions for blastocyst injection of correctly targeted and karyo-
typically normal ES clones and breeding to generate mice homozy-fibroblasts from Jak2-deficient embryos demonstrated
gous for the mutated Jak2 gene were performed essentially as de-that Jak2 is not essential for the response to IL-6. The
scribed (van Deursen et al., 1993). Nine independent ES clones wereIL-6 family of cytokines utilizes a common signaling
injected, of which four gave germline transmission. The mice were
chain, referred to as gp130 or the highly related LIFRb maintained under specific pathogen-free (SPF) conditions. Mouse-
chain, that associates with and activates multiple Jaks tail DNA was prepared by using QIAamp tissue kit (Qiagen) or from
(Andus et al., 1988; Narazaki et al., 1994; Stahl et al., approximately 1 mm tail snips of neonatal pups as described (Hogan
et al., 1994). Genotyping of mice was performed by Southern blot1994). As with G-CSF, studies with mutant cell lines
analysis or by PCR of tail DNA. For the PCR assay, approximatelylacking various Jaks indicated that Jak1 was critical for
200 ng of tail DNA was amplified per 50 ml reaction using 2.5 UIL-6 signaling (Guschin et al., 1995). The results with
AmpliTaq Gold (Perkin-Elmer) in PCR buffer II with a final concentra-
Jak2-deficient fibroblasts demonstrate that Jak2 is not tion of each dNTP at 0.2 mM, MgCl2 at 1.5 mM. Multiplex PCR with
essential for an IL-6 response. However, as indicated three primers per reaction were used in the Jak2 assay. For the
by Rodig et al. (1998), Jak1 is essential for the response assay, JF1 primer (59-TGCCAGGTGGACGTGTTTAAAT-39) at 0.4mM,
JR1 primer (59-AGGCATGCAATACCGAGTGTTG-39) at 0.4 mM, andof cytokines that utilize gp130.
NEOF1 primer (59-ATCTCCTGTCATCTCACCTTG-39) at 0.4 mM pro-Among thecytokines that have been shown toactivate
duced an 870 bp and 280 bp fragment from the mutant and wild-Jak2 are the growth hormone (Artgetsinger et al., 1993)
type alleles, respectively. The PCR cycle profile on a PTC-200 (MJ
and prolactin (Campbell et al., 1994). Because of the Research) was as follows: 1 cycle at 948C for 10 min followed by
embryonic lethality of the phenotype and the lack of 30 cycles at 948C for 1 min, 558C for 30 s, 728C for 1 min with 5 s
expression of the receptors for these cytokines in fibro- autoextension in every cycle.
blasts, we have not had the opportunity to determine
Colony Assayswhether Jak2 is essential for their function. However,
Cells were prepared from livers of d10-12 embryos in a-MEM me-since the receptors are highly related structurally and
dium (GIBCO/BRL) containing 2% fetal bovine serum (FBS) (Stem-functionally to the receptors for Epo and Tpo, we would
Cell Technologies) and counted in the presence of 3% acetic acid
anticipate that their functions would also be absent in to lyse the erythrocytes. Diluted cell suspensions and recombinant
Jak2-deficient animals. We are currently attempting to cytokines specific for each of the assays (see below) were mixed
use fetal liver rescues to obtain mice in which the hema- with MethoCult M3230 (StemCell Technologies). This gave a final
concentration of 0.9% methylcellulose, 30% FBS, 1% bovine serumtopoietic system is rescued butwould be otherwise Jak2
albumin, 0.1mM 2-mercaptoethanol, and 2 mM L-glutamine. Assaysdeficient to address specifically the role of Jak2 in the
were plated in 35 mm culture dishes in duplicate and cultured atresponse to growth hormone or prolactin.
378C, 5% CO2. For the CFU-E assay, 5 3 104 cells/dish were culturedTogether the results demonstrate that Jak2 is essen- in 0.2 U/ml recombinant human erythropoietin, rhEpo (Amgen), and
tial for the function of a variety of cytokine receptors. benzidine-positive CFU-E colonies were scored at day 3. For the
Equally striking is the lack of an effect in any of the BFU-E assay, 1 3 105 cells/dish were cultured in 3 U/ml rhEpo
and 10 ng/ml recombinant murine IL-3, rmIL-3 (R&D Systems), andsignaling pathways required for normal development to
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benzidine-positive BFU-E colonies were scored at day 8. For the Generation of Ecotropic LJAK2SN Retroviral
Producer CellsCFU-Mix assay, 5 3 104 cells/dish were cultured in 10 ng/ml rmIL-3
or 1 3 105 cells/dish were cultured in 50 ng/ml rmSCF (R&D Sys- High titer ecotropic LJAK2SN producer cell lines were obtained by
transducing GP1E86 packaging cells with high titer amphotrophictems), and colonies were scored at day 12. For the CFU-Meg assay,
5 3 105 cells/dish were cultured in 50 ng/ml recombinant human LJAK2SN a total of six times over 3 days. The transduced GP1E86
cells were then plated and placed under G418 (500 mg/ml) selectionthrombopoietin, rhTpo (Genzyme), and colonies were scored at day
8. For the CFU-GM and CFU-M assay, 5 3 104 cells/dish were for 14 days. The clones were subsequently pooled and used to
produce LJAK2SN retrovirus containing supernatants. The high titercultured in 10 ng/ml rmGM-CSF or 10 ng/ml rmCSF-1 (R&D Sys-
tems), and colonies were scored at day 12. For the CFU-G assay, amphotropic LJAK2SN clones were obtained by transient transfec-
tion of 293 T cells with the plasmid containing the LJAK2SN con-5 3 104 cells/dish were cultured in 10 ng/ml rhG-CSF (Amgen), and
colonies were scored at day 12. struct and a plasmid containing the retroviral gag, pol, and env
genes, whose expression is driven by the Moloney Leukemia Virus
LTR (D. Persons and E. F. V., unpublished data).Reconstitution
Fetal liver cells from wild-type or Jak2 d10-12±deficient embryos
Flow Cytometrywere used to reconstitute sublethally irradiated Jak3-deficient mice.
Thymus cells obtained from individual mice were made into single-The Jak3-deficient mice were irradiated with a total dose of 385
cell suspensions in PBS supplemented with 1% bovine serum albu-rads over a period of 3 min. A total number of 5 3 106 Jak2-deficient
min (PBS/BSA). Nonspecific staining was minimized by blockingliver cells in 150 ml of DMEM were injected retroorbitaly into Jak3-
with 10% normal mouse serum in PBS/BSA. The cells were thendeficient mice.
stained with a cocktail of fluorescein isothyocyanate (FITC)-conju-
gated rat anti-mouse CD4 (clone RM-4-4) and phycoerythrin (PE)-
Immunoprecipitation, SDS-PAGE, and Western Blotting conjugated rat anti-mouse CD8 (clone 53-6.7) in PBS/BSA for 30
Embryonic fibroblasts from Jak2 wild-type, Jak2 heterozygous, or min at 48C. The mAbs were purchased from Pharmingen (San Diego,
Jak2-deficient embryos were cultured in DMEM supplemented with CA) and can be referenced in their current catalog. Cell surface
10% fetal bovine serum. The cells were starved for 14±16 hr in expression of the markers was subsequently analyzed in a Becton-
serum-free DMEM before treated with IFNa (1000 IRU/ml), IFNg (500 Dickinson FACScan in two-color mode using CellQuest software.
IRU/ml), or IL-6 (500 ng/ml) plus soluble IL-6 receptor (500 ng/ml)
for 10 min. Cells were lysed in lysis buffer as previously described Proliferation Responses
(Wang et al., 1996). Cell lysates were centrifuged at 12,000 3 g for Single-cell suspensions of spleen cells in SMEM (Life Technologies,
15 min to remove debris, and the supernatants were incubated with Gaithersburg, MD) supplemented with 10% fetal bovine serum (At-
the indicated antisera for 2 hr. Immune complexes were precipitated lanta Biologicals, Norcross, GA), L-glutamine, pennicillin, strepto-
with protein A-Sepharose, washed three times in lysis buffer, and mycin, gentamycin (all from Life Technologies), sodium bicarbonate
then eluted with sample buffer for SDS-PAGE. Eluted proteins were (Sigma, St. Louis, MO), essential and nonessential amino acids (Life
resolved by SDS-7.5% PAGE and transferred to nitrocellulose. Mem- Technologies), and 2-mercaptoethanol (Sigma) were plated in 96-well
branes were probed by using designated sera or antibodies and round-bottomed plates (Corning, Corning, NY) at a density of 1 3
visualized with the ECL detection system (Amersham). 105 per well in 100 ml. The stimuli were anti-CD3 alone (clone 2C11,
Pharmingen, San Diego, CA) at a range of concentrations as indi-
cated or at a fixed concentration of 0.2 mg/ml in combination withNorthern Blot Analysis
several dilutions of recombinant human IL2 (Chiron, Emeryville, CA).Wild-type and Jak2-deficient primary fibroblasts were starved of
Proliferation was assessed by measuring radioactivity using a Matrixserum overnight and consequently stimulated with IFNa (1000 IRU/
9600 beta counter (Packard, Meriden CT) 18 hr after adding 1 mCi/ml), IFNg (500 IRU/ml), or IL-6 (500 ng/ml) plus soluble IL-6 receptor
well 3H-thymidine (Amersham Life Sciences, Arlington Heights, IL).(500 ng/ml) for 1 hr. Total RNA from both wild-type and Jak2-defi-
cient primary embryonic fibroblasts was prepared using the RNA-
Acknowledgmentszol-B purification method (Tel-test), and 20 mg RNA per lane was
separated on 1% formaldehyde agarose gels according to Sam-
We would like to thank Linda Snyder for her excellent technicalbrook et al (1989). The gels were blotted onto Nytran plus mem-
assistance in conducting the studies and John F. Zacher for hisbranes (Schleicher & Schuell). Hybridization was performed in a
excellent photography skills. This work was supported in part bymodified church buffer containing 600 mM phosphate buffer, 8%
Cancer Center CORE Grant CA21765, by grant RO1 DK42932 toSDS, 1 mM EDTA, 1% BSA, at 658C overnight. Interferon regulatory
J. N. I., and by the American Lebanese Syrian Associated Charities.factor 1 (IRF-1) and suppressor of cytokine signaling 1 (SOCS-1)
cDNAs wereused as probes. All probeswere labeled using a random
Received February 20, 1998; revised March 13, 1998.priming kit readiprime (Amersham). The membranes were washed
in 50 mM phosphate buffer, 5% SDS, 1 mM EDTA at 658C for 45
min. Exposure time for autoradiography ranged from 1±3 days. References
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